18β-glycyrrhetinic acid suppresses Lewis lung cancer growth through protecting immune cells from ferroptosis.
Xuan MaZhenou SunHui ChenLixing CaoShuang ZhaoLihong FanChong ZhaoShutao YinHongbo HuPublished in: Cancer chemotherapy and pharmacology (2024)
The findings of the present study unraveled a novel mechanism underlying the anti-cancer and immunomodulatory activity of 18β-GA and support that 18β-GA holds potential to be used as an immune enhancer for lung cancer prevention or treatment.